Equibles does not estimate personal net worth.
Get an email with a short summary when Cardiol Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.
Get CRDL alertsDavid Elsley is recorded as CEO at Cardiol Therapeutics Inc. (CRDL). David Elsley has spoken on 2 investor events across 1 company, most recently for Cardiol Therapeutics Inc. on September 14, 2026. Cardiol Therapeutics Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“And just perhaps on that, any color from the path of last patient in to top line data? uh so i'll leave the path from last patient into top line data for future guidance uh once the database is locked out in terms of enrollment we have guided the public we've advised that we were 75 enrollment some time ago we have an…”
“Yeah, I think an important point to make is really the biology of recurrence is the same, whether it's coming off an IL-1 blocker, whether it's a first episode of recurrent pericarditis, or whether it's non-response to any other therapeutic regimen.”
Drug Manufacturers - Specialty & Generic · Healthcare
CEO
